As adjuvant therapy, he continued, the study that really hit the airwaves was the OlympiA trial, which evaluated olaparib in 1, 836 women with HER2 negative germline BRCA mutated early breast cancer considered at high risk for disease progression generic priligy 2011 Mar 30; 52 4 2006 49
As adjuvant therapy, he continued, the study that really hit the airwaves was the OlympiA trial, which evaluated olaparib in 1, 836 women with HER2 negative germline BRCA mutated early breast cancer considered at high risk for disease progression generic priligy 2011 Mar 30; 52 4 2006 49